Current pathological and clinical aspects of Buerger's disease in Japan

Annals of Vascular Surgery

Volumn 20, Issue 1, 2006, Pages 148-156

  Kobayashi, Masayoshi ^a   Nishikimi, Naomichi ^a   Komori, Kimihiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CILOSTAZOL; PROSTACYCLIN; PROSTAGLANDIN E1; TICLOPIDINE;

BUERGER DISEASE; CLINICAL FEATURE; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MEDICAL RECORD; PATHOGENESIS; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; SMOKING; SYMPTOMATOLOGY;

EID: 29744453334     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-9436-2     Document Type: Review

References (28)

1. Adar R, Papa MZ, Halpern Z, et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983;308:1113-1116.
2. Eichhorn J, Sima D, Lindschau C, et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998;315:17-23.
3. Lee T, Seo J-T, Sumpio BE, et al. Immunologic analysis of arterial tissue in Buerger's disease. Eur J Endovasc Surg 2003;25:451-457.
4. Kobayashi M, Kurose K, Kobata T, Hida K, Sakamoto S, Matsubara J. Ischemic intestinal involvement in a patient with Buerger disease: case report and literature review. J Vasc Surg 2003;38:170-174.
5. Winiwater F. Uber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangan des Fusses. Arch Klin Chir 1878;23:202-226.
6. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-580.
7. Wessler S, Ming SC, Gurewich V, Freiman DG. A critical evaluation of thromboangiitis obliterans. The case against Buerger's disease. N Engl J Med 1960;262: 1149-1162.
8. Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol. Jpn 1989;39: 153-157.
9. Papa MZ, Adar R. A critical look at thromboangiitis obliterans (Buerger's disease) In: Goldstone J, ed. Perspectives in Vascular Surgery, vol. 5. Quality Medical Publishing: St Louis, 1992, pp 1-21.
10. Shionoya S. Pathology. In: Shionoya, S, ed. Buerger's Disease. University of Nagoya Press: Nagoya, 1990, pp 57-79.
11. McKusick VA. Buerger's disease: a distinct clinical and pathologic entity. JAMA 1962;181:93-100.
12. Adar R. Buerger's disease - the need for diagnostic criteria. Surgery 1974;76:848.
13. Shionoya S. Diagnostic criteria of Buerger's disease. Int. J Cardiol 1998;66(Suppl 1):243-245.
14. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998; 124:498-502.
15. Shionoya S. What is Buerger's disease? World J Surg 1983;7: 544-551.
16. Kobayashi M, Ito M, Nakagawa A, Nishikimi N, Nimura Y. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999;29:451-458.
17. Lie JT. Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. Rheum Dis Clin North Am 1990;16:269-292.
18. Shionoya S. Buerger's disease (thromboangiitis obliterans) In: Rutherford, RB, ed. Vascular Surgery. 4th ed. WB Saunders: Philadelphia, 1995, pp 235-45.
19. Matsushita M, Kuzuya A, Kobayashi K, et al. Buerger's disease in a 19-year-old woman. J. Vasc. Surg 2003;38:175-179.
20. Foliart D, Benowitz NL, Becker CE. Passive absorption of nicotine in airline flight attendants. N Engl J Med 1983;308: 1105.
21. Mattson ME, Boyd G, Byar D, et al. Passive smoking on commercial airline flights. JAMA 1989;261:867-872.
22. Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurement in patients with Buerger's disease - effects of active and passive smoking on the disease process. J Vasc Surg 1991;14:53-58.
23. Nishikimi N. Fate of limbs with failed vascular reconstruction in Buerger's disease patients. Int. J. Cardiol 2000;75: 183-185.
24. Corelli F. Buerger's disease: cigarette smoker disease may always be cured by medical therapy alone. Uselessness of operative treatment. J Cardiovasc Surg 1973;14:28-36.
25. de Takats G. Diagnosis and management of Buerger's disease. Postgrad Med 1948;3:185-191.
26. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27: 729-749.
27. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitides. Best Pract Res Clin Rheumatol 2002;16:833-845.
28. Watts RA, Scott DG. Epidemiology of the vasculitides. Curr Opin Rheumatol 2003;15:11-16.